Literature DB >> 29183800

Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.

A Garcês1, M H Amaral2, J M Sousa Lobo3, A C Silva4.   

Abstract

Cutaneous use of lipid nanoparticles (solid lipid nanoparticles, SLN and nanostructured lipid carriers, NLC) has been showing promising results. These systems consist of low viscosity aqueous dispersions, being usually employed by means of semi-solid formulations with adequate consistency for skin application. This review addresses the cutaneous use of lipid nanoparticles for therapeutic and cosmetic applications. Initially, general information related to pharmaceutical semi-solid formulations is presented. Afterwards, the effects of SLN and NLC on the skin, and technological aspects related to semi-solid systems based on SLN or NLC are described. Finally, the most relevant studies related to the formulations based on SLN and NLC, for cosmetic and therapeutic applications, are reported. Notwithstanding the cutaneous use of SLN and NLC has been proposed for both local and transdermal delivery, the reported studies show promising results only for local application. In this sense, more research is required to better understanding the interaction mechanisms of lipid nanoparticles with skin lipids. Furthermore, the development of standard methods for skin experiments with nanoparticles is necessary.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cutaneous use; Nanostructured lipid carriers; Skin formulations; Solid lipid nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 29183800     DOI: 10.1016/j.ejps.2017.11.023

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  40 in total

1.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

2.  Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity.

Authors:  Md Meraj Anjum; Krishna Kumar Patel; Deepa Dehari; Nidhi Pandey; Ragini Tilak; Ashish Kumar Agrawal; Sanjay Singh
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

3.  Solid-lipid nanoparticles (SLN)s containing Zataria multiflora essential oil with no-cytotoxicity and potent repellent activity against Anopheles stephensi.

Authors:  Hamid Reza Kelidari; Mohammad Djaefar Moemenbellah-Fard; Katayon Morteza-Semnani; Fatemeh Amoozegar; Marziae Shahriari-Namadi; Majid Saeedi; Mahmoud Osanloo
Journal:  J Parasit Dis       Date:  2020-10-07

4.  Assessment to the Antifungal Effects in vitro and the Ocular Pharmacokinetics of Solid-Lipid Nanoparticle in Rabbits.

Authors:  Zhen Liang; Zhen Zhang; Jingjing Yang; Ping Lu; Tianyang Zhou; Jingguo Li; Junjie Zhang
Journal:  Int J Nanomedicine       Date:  2021-11-30

5.  Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity.

Authors:  Violeta Rodriguez-Ruiz; José Ángel Salatti-Dorado; Abolfazl Barzegari; Alba Nicolas-Boluda; Amel Houaoui; Carmen Caballo; Noelia Caballero-Casero; Dolores Sicilia; Jorge Bastias Venegas; Emmanuel Pauthe; Yadollah Omidi; Didier Letourneur; Soledad Rubio; Virginie Gueguen; Graciela Pavon-Djavid
Journal:  Molecules       Date:  2018-10-11       Impact factor: 4.411

6.  Oleic acid-loaded nanostructured lipid carrier inhibit neutrophil activities in the presence of albumin and alleviates skin inflammation.

Authors:  Chun-Yu Chen; Ying-Hsuan Lee; Shih-Hsin Chang; Yung-Fong Tsai; Jia-You Fang; Tsong-Long Hwang
Journal:  Int J Nanomedicine       Date:  2019-08-16

7.  Development and Statistical Optimization of Solid Lipid Nanoparticle Formulations of Fluticasone Propionate.

Authors:  Gülin Amasya; Ceyda Tuba Şengel TÜrk; Ulya Badilli; Nilüfer Tarimci
Journal:  Turk J Pharm Sci       Date:  2020-08-28

8.  Novel rhein-phospholipid complex targeting skin diseases: development, in vitro, ex vivo, and in vivo studies.

Authors:  Heba M K Ebada; Maha M A Nasra; Yosra S R Elnaggar; Ossama Y Abdallah
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

9.  Preformulation and characterization of raloxifene-loaded lipid nanoparticles for transdermal administration.

Authors:  Guilherme L Alves; Fernanda V Teixeira; Priscila Bianca Rodrigues da Rocha; Anna Paula Krawczyk-Santos; Lígia Marquez Andrade; Marcilio Cunha-Filho; Ricardo N Marreto; Stephânia F Taveira
Journal:  Drug Deliv Transl Res       Date:  2021-03-07       Impact factor: 4.617

Review 10.  Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.

Authors:  Bingtao Zhai; Yiying Zeng; Zhaowu Zeng; Nana Zhang; Chenxi Li; Yijun Zeng; Yu You; Shuling Wang; Xiabin Chen; Xinbing Sui; Tian Xie
Journal:  Int J Nanomedicine       Date:  2018-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.